India
· Delayed Price · Currency is INR Laurus Labs Company Description
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas.
It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products.
Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field.
Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
| Country | India |
| Founded | 2005 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 6,007 |
| CEO | Satyanarayana Chava |
Contact Details
Address: Serene Chambers Hyderabad, Andhra Pradesh 500034 India | |
| Phone | 91 40 3980 4333 |
| Website | lauruslabs.com |
Stock Details
| Ticker Symbol | 540222 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Satyanarayana Chava | Chief Executive Officer |
| Vantaram Venkata Kumar | Chief Financial Officer |
| B. V. R. K. Suryadevara Rao | Chief Operating Officer |
| Vivek Kumar | Head of Investor Relations |